Page 31 - GALENIKA MEDICAL JOURNAL

Literatura 18. Elbornsson M, Götherström G, Bosæus I, Bengtsson BÅ, Johannsson
G, Svensson J. Fifteen years of GH replacement improves body
composition and cardiovascular risk factors. Eur J Endocrinol. 2013 Apr
1. Ho KK; 2007 GH Deficiency Consensus Workshop Participants. 15;168(5):745-53.
Consensus guidelines for the diagnosis and treatment of adults with 19. Appelman-Dijkstra NM, Rijndorp M, Biermasz NR, Dekkers OM, Pereira
GH deficiency II: a statement of the GH Research Society in association AM. Effects of discontinuation of growth hormone replacement in adult
with the European Society for Pediatric Endocrinology, Lawson GH-deficient patients: a cohort study and a systematic review of the
Wilkins Society, European Society of Endocrinology, Japan Endocrine literature. Eur J Endocrinol. 2016 Jun;174(6):705-16.
Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007
Dec;157(6):695-700. 20. Shimon I, Badiu C, Bossowski A, Doknic M, Dzivite-Krisane I, Hána V, et
al. Adult growth hormone deficiency in CEE region: Heterogeneity of
2. Van Bunderen CC, Olsson DS. Meta-analysis of mortality in adults the patient pathway. Growth Horm IGF Res. 2019 Jun-Aug;46-47:44-9.
with growth hormone deficiency: Does growth hormone replacement
therapy really improve mortality rates? Best Pract Res Clin Endocrinol 21. Shen YY, Ma JN, Ren ZY, Liu J, Zhou XY, Xie XR, et al. Effects of 18 Months
Metab. 2023 Dec;37(6):101835. of Growth Hormone Replacement Therapy on Bone Mineral Density in
3. Doknić M, Pekić S, Miljić D, Soldatović I, Popović V, Stojanović M, et Patients with Adult Growth Hormone Deficiency: A Retrospective Study.
Int J Endocrinol. 2023 Mar 31;2023:4988473.
al. Etiology of Hypopituitarism in Adult Patients: The Experience of a
Single Center Database in the Serbian Population. Int J Endocrinol. 22. Mericq V, Iñiguez G, Pinto G, Gonzalez-Briceño LG, Samara-Boustani D,
2017;2017:6969286. Thalassinos C, et al. Identifying patient-related predictors of permanent
4. Doknic M, Savic D, Manojlovic-Gacic E, Savo R, Bokun J, Milenkovic T, et growth hormone deficiency. Front Endocrinol (Lausanne). 2023 Oct
10;14:1270845.
al. Clinical case seminar: Familial intracranial germinoma. Endokrynol
Pol. 2018;69(5):612-8. 23. Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G, Mattsson
AF, et al. Long-term Safety of Growth Hormone in Adults With Growth
5. Doknic M, Gasic V, Stojanovic M, Pavlovic S, Marinkovic S, Miljic D, et al. Hormone Deficiency: Overview of 15 809 GH-Treated Patients. J Clin
Hypopituitarism in five PROP1 mutation siblings: long-lasting natural Endocrinol Metab. 2022 Jun 16;107(7):1906-19.
course and the effects of growth hormone replacement introduction in
middle adulthood. Pituitary. 2020 Aug;23(4):400-8. 24. Van Bunderen CC, Glad C, Johannsson G, Olsson DS. Personalized
6. Höybye C, Sävendahl L, Christesen HT, Lee P, Pedersen BT, Schlumpf approach to growth hormone replacement in adults. Arch Endocrinol
Metab. 2019 Nov-Dec;63(6):592-600.
M, et al. The NordiNet® International Outcome Study and NovoNet®
ANSWER Program®: rationale, design, and methodology of two 25. Höybye C. Comparing treatment with daily and long-acting growth
international pharmacoepidemiological registry-based studies hormone formulations in adults with growth hormone deficiency:
monitoring long-term clinical and safety outcomes of growth hormone Challenging issues, benefits, and risks. Best Pract Res Clin Endocrinol
therapy (Norditropin®). Clin Epidemiol. 2013 Apr 26;5:119-27. Metab. 2023 Dec;37(6):101788.
7. Steyn FJ, Tolle V, Chen C, Epelbaum J. Neuroendocrine Regulation of 26. Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM,
Growth Hormone Secretion. Compr Physiol. 2016 Mar 15;6(2):687-735. et al. American Association of Clinical Endocrinologists and American
College of Endocrinology Guidelines for management of growth
8. Mancini A, Arosio M, Kreitschmann-Andermahr I, Persani L. Editorial: hormone deficiency in adults and patients transitioning from pediatric
New Insights and Controversies in Diagnosis and Treatment of Adult to adult care. Endocrine Practice. 2019; 25:1191-232.
Growth Hormone Deficiency. Front Endocrinol (Lausanne). 2022 Jan
10;12:819527. 27. Boguszewski CL. Safety of long-term use of daily and long-acting
9. Yuen KCJ, Johannsson G, Ho KKY, Miller BS, Bergada I, Rogol AD. growth hormone in growth hormone-deficient adults on cancer risk.
Best Pract Res Clin Endocrinol Metab. 2023 Dec;37(6):101817.
Diagnosis and testing for growth hormone deficiency across the ages: a
global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr 28. Bolier M, Van der Lelij AJ, Janssens GO, Van den Heuvel-Eibrink MM,
Connect. 2023 Jun 12;12(7):e220504. Neggers SJCMM. Long-term safety of growth hormone replacement
10. Yuen KCJ. Adult growth hormone deficiency guidelines: more difficult therapy in survivors of cancer and tumors of the pituitary region.
Endocr Relat Cancer. 2023 Jun 2;30(7):e230026.
than it seems to incorporate into clinical practice universally. Eur J
Endocrinol. 2021 Apr;184(4):C5-C7. 29. Di Somma C, Scarano E, Arianna R, Romano F, Lavorgna M, Serpico
D, et al. Long-Term Safety of Growth Hormone Deficiency Treatment
11. Götherström G, Johannsson G, Svensson J. Effects of 18 months of GH in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH
replacement on cardiovascular risk factors and quality of life in GH Therapy on the Neoplastic Risk? J Clin Med. 2023 Jan 13;12(2):662.
deficient adults; a randomized controlled trial using a fixed very low
and a standard dose of GH. Growth Horm IGF Res. 2022 Dec;67:101510. 30. Garmes HM, Castillo AR, Monte Alegre S, de Souza AL, Atala YB, Zantut-
12. Elbornsson M, Horvath A, Götherström G, Bengtsson BÅ, Johannsson G, Wittmann DE. Childhood-Onset GH Deficiency versus Adult-Onset
GH Deficiency: Relevant Differences Regarding Insulin Sensitivity.
Svensson J. Seven years of growth hormone (GH) replacement improves Metabolites. 2022 Dec 11;12(12):1251.
quality of life in hypopituitary patients with adult-onset GH deficiency.
Eur J Endocrinol. 2017 Feb;176(2):99-109. 31. Spaziani M, Tarantino C, Tahani N, Gianfrilli D, Sbardella E, Isidori AM,
13. Stojanovic M, Popevic M, Pekic S, Doknic M, Miljic D, Medic-Stojanoska et al. Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone
Deficiency During the Transition Period: Review of the Literature. Front
M, et al. Serum Insulin-Like Growth Factor-1 (IGF-1) Age-Specific Endocrinol (Lausanne). 2021 Feb 24;12:634288.
Reference Values for Healthy Adult Population of Serbia. Acta
Endocrinol (Buchar). 2021 Oct-Dec;17(4):462-71. 32. Yuen KCJ, Alter CA, Miller BS, Gannon AW, Tritos NA, Samson SL, et al.
Adult growth hormone deficiency: Optimizing transition of care from
14. Doknic M, Miljic D, Pekic S, Stojanovic M, Savic D, Manojlovic-Gacic E, pediatric to adult services. Growth Horm IGF Res. 2021 Feb;56:101375.
et al. Single center study of 53 consecutive patients with pituitary stalk
lesions. Pituitary. 2018 Dec;21(6):605-14. 33. Doknic M, Stojanovic M, Soldatovic I, Milenkovic T, Zdravkovic V, Jesic
M, et al. Mapping the journey of transition: a single-center study of
15. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, 170 childhood-onset GH deficiency patients. Endocr Connect. 2021 Aug
et al. Sensitivity and specificity of the macimorelin test for diagnosis of 13;10(8):935-946.
AGHD. Endocr Connect. 2021 Jan;10(1):76-83.
16. Gasco V, Ferrero A, Bisceglia A, Prencipe N, Cambria V, Bioletto F, et
al. The Cut-off Limits of Growth Hormone Response to the Insulin Konflikt interesa: Nema
Tolerance Test Related to Body Mass Index for the Diagnosis of Adult
Growth Hormone Deficiency. Neuroendocrinology. 2021;111(5):442-50. Primljeno: 19. 02. 2024.
17. Rochira V, Mossetto G, Jia N, Cannavo S, Beck-Peccoz P, Aimaretti G, Prihvaćeno: 29. 02. 2024.
et al. Analysis of characteristics and outcomes by growth hormone Onlajn: 31. 03. 2024.
treatment duration in adult patients in the Italian cohort of the
Hypopituitary Control and Complications Study (HypoCCS). J Endocrinol
Invest. 2018 Nov;41(11):1259-66.

REVIJALNI RADOVI Galenika Medical Journal, 2024; 3(9):23-29. 29